Back to the feed
In brief
On 30.10.2026, a person holding the function "Executive member of the board of directors / senior management" at PolyPeptide Group AG disclosed a sale worth CHF 10’095’679 to SIX Exchange Regulation.
This is the largest management sale disclosed at PolyPeptide Group AG over the previous 12 months (12 sales in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of PolyPeptide Group AG declared a "Sale" transaction on 30.10.2026.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date30.10.2026
Issuing companyPolyPeptide Group AG
ISINCH1110760852
Transaction sideSale
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
SecurityN/A
Quantity227’842
Unit priceCHF 44.31
AmountCHF 10’095’679
ConditionsTendering of shares into the public tender offer of
Samsung Peptide AG. End of the additional
acceptance period (Nachfrist) of the offer: 30
October 2026.
ExchangeXSWX
Notification IDT1QAU00071
Other PolyPeptide Group AG insider transactions
- Sale · Executive member of the board of directors / senior management30.10.2026CHF 6’321’929
- Sale · Executive member of the board of directors / senior management30.10.2026CHF 156’769
- Sale · Non-executive member of the board of directors30.10.2026CHF 141’819
- Sale · Non-executive member of the board of directors30.10.2026CHF 190’090
- Sale · Executive member of the board of directors / senior management30.10.2026CHF 296’301
These figures aggregate public disclosures. They are not investment advice.